FBRX - NASDAQ

Forte Biosciences, Inc.

FBRX·NASDAQ

$16.69

-8.2%

HealthcareBiotechnology

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$231.75M

EPS-4.7100

P/E Ratio-3.54

Earnings Date08/13/2026

fbrx

Net Cash Provided by Financing Activities

Last Annual Value

69.36M

3-Year CAGR

112%

5-Year CAGR

10-Year CAGR

Adjust for Inflation

Forte Biosciences, Inc. Competitors Analysis of Net Cash Provided by Financing Activities

FBRX · NASDAQ

Company	Net Cash Provided by Financing Activities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Forte Biosciences, Inc. NASDAQ:FBRX	69.36M	41.1%	N/A	40.4%
Nkarta, Inc. NASDAQ:NKTX	141.00K	-41.1%	-34.9%	N/A
Cardiff Oncology, Inc. NASDAQ:CRDF	2.58M	N/A	-40.8%	1.2%
Seres Therapeutics, Inc. NASDAQ:MCRB	13.90M	-42.1%	63.8%	20.6%
Tonix Pharmaceuticals Holding Corp. NASDAQ:TNXP	214.53M	80.4%	0.2%	26.5%
Actuate Therapeutics Inc NASDAQ:ACTU	23.72M	79.0%	N/A	N/A
Applied Therapeutics, Inc. NASDAQ:APLT	113.81M	15.1%	8.8%	N/A
Fate Therapeutics, Inc. NASDAQ:FATE	5.49M	301.2%	-58.6%	-21.0%
PepGen Inc. NASDAQ:PEPG	107.98M	N/A	-6.1%	N/A
Alector, Inc. NASDAQ:ALEC	20.21M	99.4%	-7.8%	N/A
Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP	77.43M	N/A	4.9%	16.5%

Forte Biosciences, Inc. Fair Value Envelope

FBRX · NASDAQ

Our analysis suggests that FBRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $16.69, this represents a potential HIDDEN relative to our calculated worth for Forte Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $16.69

Related Guides

Blog Categories

Continue your FBRX research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.